Author:
Glavinić-Mijić Marija,Popović Slobodanka,Simić-Milovanović Anamaria
Abstract
Introduction. Destroyed lung syndrome is a severe destruction of the pleural parenchyma due to lung infection, mostly caused by tuberculosis. Besides tuberculosis, necrotizing pneumonia may also lead to this disease complication. Pleural empyema is a frequent consequence of the destroyed lung syndrome. Pleural empyema may occur during the COVID-19 infection and is negatively correlated with a favorable disease outcome. Case report. A male 50 y/o showed up during the on-call shift during the winter COVID-19 wave with a medical report from the Internal medicine clinic. His personal history is significant for his pneumonectomy in 2016. In the past two months, he had been treated for pneumonia and COVID-19 infection with antibiotics and corticosteroid therapy. Due to prolonged malaise and tachycardia his GP referred him to yet another chest X-ray and lab work. The chest X-ray showed pleural effusion, so he was promptly referred to an on-call hospital. The on-call physician, after looking into the hospital reports, consulted an internal medicine doctor and it was decided to refer the patient to a thoracic surgeon. He was hospitalized for pleural empyema and treated with thoracic drainage using the system of active aspiration. A year later, he feels well, and he regained his appetite, and body mass, with occasional leaking from the thoracic fistule. Conclusion. This case report shows a recurrence of pleural empyema in a patient with pneumonectomy due to necrotizing pneumonia and destroyed lung syndrome, complicated by COVID-19 infection. We aimed to draw the attention of GPs to diseases and disease complications that are rarely met in GP practice and are not otherwise treated on the primary healthcare level.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference18 articles.
1. Crespo GM, Martínez AF, González CFJ. Destroyed lung complicated with empyema. Imaging Med 2016;8(4):113-5;
2. Bedawi EO, Ricciardi S, Hassan M, Gooseman MR, Asciak R, Castro-Añón O, et al. ERS/ESTS statement on the management of pleural infection in adults. Eur Respir J 2023;61(2):2201062. doi: 10.1183/13993003.01062-2022;
3. Hayhoe BWJ, Powel RA, Barber S, Nicholls D. Impact of COVID-19 on individuals with multimorbidity in primary care. Br J Gen Pract 2021;72(714):38-9. doi: 10.3399/bjgp22X718229;
4. Jovanovic V, Ivanovic I, Krstic M, Medarevic A, Tomasevic S. Zdravstvenostatistički godišnjak Republike Srbije 2021. Institut za javno zdravlje Srbije "Dr Milan Jovanović Batut", Beograd; 2022;
5. Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther 2022;7(1):141. doi: 10.1038/s41392-022-00997-x;